Log In
BCIQ
Print this Print this
 

Nipent, pentostatin

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionPurine analog that inhibits adenosine deaminase (ADA)
Molecular Target Adenosine deaminase (ADA)
Mechanism of ActionAdenosine deaminase (ADA) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHairy cell leukemia
Indication DetailsTreat hairy cell leukemia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$1,700.0M

$1,700.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/03/2015

$1,700.0M

$1,700.0M

0

Get a free BioCentury trial today